Phaos Technology Holdings (Cayman) (POAS) Assets (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) posted Assets of $1.3 million for Q4 2025, down 11.65% on a QoQ basis from $1.4 million in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Assets (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman)'s Assets history runs 2 years deep, the most recent figure standing at $1.3 million for Q4 2025.

Quarterly Assets changed N/A year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, down 62.38% from the prior year.
Assets was $1.3 million for Q4 2025 at Phaos Technology Holdings (Cayman), down from $1.4 million in the prior quarter.
Across five years, Assets topped out at $3.8 million in Q2 2024 and bottomed at $1.3 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets (Qtr)
1	Abbott Laboratories	182.32 Bn	175.03 Bn	6.27 Bn	110.43 Bn
2	Stryker	128.82 Bn	125.95 Bn	3.81 Bn	46.29 Bn
3	Medtronic	108.46 Bn	99.24 Bn	6.41 Bn	93.03 Bn
4	Boston Scientific	68.25 Bn	66.79 Bn	3.61 Bn	44.35 Bn
5	Edwards Lifesciences	47.64 Bn	43.97 Bn	1.29 Bn	13.32 Bn
6	Dexcom	28.55 Bn	27.43 Bn	750.30 Mn	6.63 Bn
7	GE HealthCare Technologies	28.51 Bn	26.22 Bn	1.98 Bn	37.13 Bn
8	Smith & Nephew	26.96 Bn	26.39 Bn	-	10.46 Bn
9	Koninklijke Philips	25.42 Bn	22.29 Bn	2.07 Bn	31.92 Bn
10	Phaos Technology Holdings (Cayman)	6.17 Mn	6.12 Mn	-	1.28 Mn

Download Data